Dust mites are one of the most common allergies and asthma triggers that sneak inside households. While these microscopic creatures resemble small bugs, dust mites don’t truly leave bites on the skin. They can, however, cause skin rashes. Dust mites can also be a reason for other allergy symptoms, such as sneezing and postnasal drip. Dust mites should not be confused with bedbugs, which are a separate type of species that leave visible bites on the skin. However, it is impossible to completely remove dust mites from a house. All these factors are predicted to expand the demand for dust-mite treatments market across the world during the forecast period.
Dust mites feed primarily on skin cells. A single person sheds enough skin to serve millions of dust mites a day, which means a home can have millions of dust mites in it. The skin cells shed by people and pets can be found deep within the fabric surfaces of a home, such as in the carpets and couches. Although, dust mites are nearly impossible to get rid of entirely, there are treatments a person can take to help rid their homes of most of these allergy-causing arthropods. The treatments include decongestants to help dry up and keep nasal passages clear. Also, antihistamines help to reduce allergic reactions, such as watery eyes. Nasal steroids can be used for inflammation and open up the nasal passages. Other treatments like leukotriene inhibitors, such as Singulair (montelukast) which block a pathway in the allergy response is also a major factor to boost the dust-mite treatment market globally.

Looking for a complete analysis of competitive dynamics? Request a PDF sample here.
https://industryprobe.com/request/request_a_sample/Dust-Mite-Treatment-Market

The report identifies and analyzes segments’ efficiency based on CAGR and market share index across North America, Europe, Asia Pacific, Middle East & Africa, and South America. The same has also been provided for each segmentation category, i.e., form, category, type, end-user, distribution channel, and region in the scope of the study. The report also covers a region-wise share analysis of the dust-mite treatment market. The report focuses on various key trends impacting the growth of the global dust-mite treatment market. Some of the trends include the focus on health, cleanliness, etc. Moreover, the study identifies the bargaining power of suppliers, bargaining power of buyers, the threat from new entrants, threat from substitutes, and the degree of competition in the global dust-mite treatment market has been included in the report.
Key players operating in the global dust mite treatments market include HAL Allergy B.V., Shionogi & Co., Ltd., Sanofi, Teva Pharmaceutical Industries Ltd., ICB PHARMA, Merck & Co., Inc., Allergy Therapeutics, Torii Pharmaceutical Co., Ltd, Ergomed Plc, Circassia, Stallergenes Greer, Merck KGaA, ASIT biotech, Trio Lifescience Private Limited., and Bayer AG, among others. These market opponents are focused on the enactment of market strategies such as mergers & acquisitions and geographical expansion. Furthermore, market players are more focused on product development and enhancement to have a competitive advantage over others.

Originally published on-
http://industryprobe.weebly.com/blog/an-average-households-contains-millions-of-dust-mites-in-it

About Us
Industry Probe is a global market intelligence and advisory firm with an unwavering purpose to help businesses achieve strategic objectives through a varied range of offerings. Based on a unique amalgamation of our big data technology and human intelligence, our services are dedicated to serve the businesses operating in the consumer goods and industrial machinery sectors. Our offerings comprises syndicated research, strategic consulting & advisory services, competitive intelligence, and full time engagement to bring true & actionable insights into our clients’ business environment. Combining research & technology adoption, playing the perfect mix of the best data, and centered on consumer goods & industrial machinery sectors, Industry Probe believes in targeting one industry at a time.

Contact Us
1441 Broadway, 6th Floor – # 6131
New York, NY 10018
Email: [email protected]
Website: https://www.industryprobe.com/